Blended Interferon-Alpha and Interleukin-2 Therapy
A mixed preparation of recombinant interferon-alpha and interleukin-2 for treating viral infections and boosting immune response in immunotherapy. Classified in HTS 3002.14.00.90 as mixed immunological products (interferons and interleukins per chapter notes) not for retail sale.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If supplied unmixed as separate vials
Chapter note 3(a) treats unmixed products separately from mixtures like colloidal solutions or blends.
If for therapeutic use in measured doses
Dosed medicinal preparations shift to chapter 30 headings 3003/3004, excluding bulk mixes.
If deemed diagnostic reagents
Diagnostic-use immunologicals go to 3822; therapeutic excludes per chapter exclusions.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right HTS code — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Include proof of Good Manufacturing Practice (GMP) compliance and stability data for cold chain transport
• Label clearly as mixed per chapter note 3(b); bulk hospital supply avoids retail subheading pitfalls
Related Products under HTS 3002.14.00.90
Antibody Fragment Conjugate Mixture for Targeted Therapy
Blend of antibody fragments and conjugates for precise immune targeting in autoimmune diseases. HTS 3002.14.00.90 for mixed, non-retail immunological products including antibody conjugates per chapter notes.
Mixed Monoclonal Antibody Cocktail for Cancer Immunotherapy
This product is a blend of multiple monoclonal antibodies (e.g., pembrolizumab and nivolumab derivatives) designed for immunotherapy treatment of solid tumors. It falls under HTS 3002.14.00.90 as mixed immunological products not in measured doses or retail packaging, per chapter notes defining immunological products as peptides/proteins regulating immunological processes.
Cytokine Mixture for Immunomodulation (TNF and Growth Factors)
Bulk mixed solution of tumor necrosis factors (TNF) and growth factors for regulating immune responses in clinical settings. HTS 3002.14.00.90 applies to these mixed immunological products (TNF/GF per notes) not in retail forms.
Hematopoietin and Colony Stimulating Factor Blend
Mixed hematopoietins and colony stimulating factors (CSF) for bone marrow stimulation in chemotherapy patients. Fits HTS 3002.14.00.90 as mixed biotech immunological products for bulk clinical use.